The wait is over…the TFOS DEWS III report has just been published in the American Journal of Ophthalmology!
Thank you again, Alcon, the Title Sponsor.
TFOS greatly appreciates the efforts of the 80 experts from 18 countries, who used an evidence-based approach and a process of open communication, dialogue and transparency to create the TFOS DEWS III report. The American Journal of Ophthalmology (AJO) has just published this report in an open access and special AJO Supplement - https://www.sciencedirect.com/special-issue/10PHL822N4T
This TFOS DEWS III report updates the recommendations and conclusions of TFOS DEWS II regarding the subclassification, diagnostic methodology, and management and therapy of dry eye disease. The TFOS DEWS III report also features a Digest, that highlights new advances in other TFOS DEWS II topics, including sex, gender, and hormones; epidemiology; pathophysiology; tear film; pain and sensation; iatrogenic dry eye; and clinical trial design. The Executive Summary of this TFOS DEWS III report will be submitted to AJO within a month, and then later published and linked to the Supplement.TFOS DEWS III presentations have just been featured at the BCLA Clinical Conference (Birmingham, UK) and are already scheduled for sessions in upcoming Argentina eye-related conferences (July), the TFOS China & 7th National Cornea Innovation Conference (Wenzhou, China, August), and the American Academy of Optometry (Boston, MA, October) and Ophthalmology (Orlando, FL, October) meetings in the USA.
The report has also just been highlighted in the June 6 issue of the ASCRS Eyeworld Weekly. TFOS expresses its sincere appreciation to Richard Parrish and Sarah Duncan Powers, the AJO Editor-in-Chief and AJO Managing Editor, respectively, for providing exceptional guidance before, during and after the submission process; and to Asja Rehse (Elsevier Publisher), Jerilyn Shola (Elsevier Associate Content Acquisition Specialist), and Avinash Kannan (Elsevier Journal Manager), for their assistance throughout this publication effort.
TFOS also expresses its gratitude to Anthony J. Bron (UK), the Chair of the TFOS DEWS, who laid the foundation for the TFOS Workshop series. His extraordinary contributions to TFOS are immeasurable. TFOS also greatly appreciates Amy Gallant Sullivan (TFOS Executive Director, France) for raising the funds that made TFOS DEWS III possible; and Sabrina Zappia (Italy) for her team’s illustrative expertise. The TFOS DEWS III effort was supported by unrestricted donations from Alcon, Bausch + Lomb, Azura, AbbVie, CooperVision, Dompé, Espansione Group, Harrow, Laboratoire Théa, SIFI, SINQI, Tarsus, Topcon and Trukera. TFOS has dedicated this TFOS DEWS III report to Claes H. Dohlman, Gary N. Foulks, Michael A. Lemp and Juan Murube del Castillo for their pioneering efforts and outstanding achievements in tear film and ocular surface research.
